Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

0.54
Delayed Data
As of May 27
 -0.02 / -3.57%
Today’s Change
0.40
Today|||52-Week Range
2.84
-50.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash12.9M45.4M19.2M20.3M
 
 
 
 
 
Short Term Investment Cash992.0K32.4M-27.0M1.1M
 
 
 
 
 
Cash & Short Term Investments13.7M46.1M26.3M20.3M
 
 
 
 
 
 
ReceivablesReceivables1.1M1.9M3.1M2.6M
 
 
 
 
 
 
InventoriesInventories1.1M1.3M----
 
 
 
 
Current AssetsOther Current Assets803.1K1.6M4.3M3.5M
 
 
 
 
 
Current Assets16.7M50.8M33.7M26.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross13.2M15.9M21.4M24.6M
 
 
 
 
 
Depreciation-2.0M-3.0M-5.4M-7.5M
 
 
 
 
 
Intangible Assets25.6M25.0M72.8M9.9M
 
 
 
 
 
Other Assets26.5M26.1M76.6M13.8M
 
 
 
 
 
Total Assets54.4M89.8M126.3M57.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.6M3.4M5.7M4.1M
 
 
 
 
 
Short Term Debt3.6M594.2K1.9M5.4M
 
 
 
 
 
Accrued Expenses687.6K1.7M1.5M3.4M
 
 
 
 
 
Other Current Liabilities2.2M3.5M5.8M8.8M
 
 
 
 
 
Other Liabilities9.9M9.8M16.2M21.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt171.5K3.6M14.7M11.4M
 
 
 
 
 
Deferred Taxes-3.6M-4.4M-18.2M-932.7K
 
 
 
 
 
Other Liabilities7.9M10.0M804.5K562.0K
 
 
 
 
 
Total Liabilities21.6M27.8M68.2M33.9M
 
 
 
 
 
 
EquityMinority Interest-287.2K-504.1K-593.3K-124.5K
 
 
 
 
 
Preferred Stock100.00100.00100.00100.00
 
 
 
 
 
Common Equity33.2M62.5M58.5M23.7M
 
 
 
 
 
Total Shareholder Equity33.2M62.5M58.5M23.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding16.4M27.2M36.8M56.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.